Wang, Z., Chu, J., Wang, Y., Huang, L., & Qian, M. (2026). Immunotherapy innovations in triple-negative breast cancer: Targeting checkpoints, combinations, and biomarkers. Oncology Reviews, 1. https://doi.org/10.3389/or.2026.1802090
Chicago Style (17th ed.) CitationWang, Zi-Xin, Ju-Hang Chu, Ya-Ru Wang, Lu-Yao Huang, and Ming-Ping Qian. "Immunotherapy Innovations in Triple-negative Breast Cancer: Targeting Checkpoints, Combinations, and Biomarkers." Oncology Reviews 2026: 1. https://doi.org/10.3389/or.2026.1802090.
MLA (9th ed.) CitationWang, Zi-Xin, et al. "Immunotherapy Innovations in Triple-negative Breast Cancer: Targeting Checkpoints, Combinations, and Biomarkers." Oncology Reviews, 2026, p. 1, https://doi.org/10.3389/or.2026.1802090.